• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/9

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

9 Cards in this Set

  • Front
  • Back
  • 3rd side (hint)

Physiochemical properties of lignocaine

- Amide LA


- pKa 7.9


- 25% unionised at pH 7.4


- Rel. lipid solubility 150


(heptane-buffer coefficient 2.9)

- Structure


- pKa


- % unionised at 7.4


- Lipid solubility

Pharmacokinetic properties of lignocaine

- PPB 70% (A1AG)


- Metabolised in liver by dealkylation (HER 0.63)


- Metabolites excreted in urine


- Elimination half-life 100 min


- Clearance reduced in presence of hepatic / cardiac failure



- Protein binding


- metabolism, HER


- excretion


- elimination half life

Pharmacodynamic properties of lignocaine

- relative potency 2


- fast onset


- moderate duration of action


- toxic plasma conc >5 mcg/ml


- max dose 3mg/kg or 7mg/kg with adrenaline

- potency


- onset


- duration


- toxic plasma conc


- safe dose

Physiochemical properties of prilocaine

- amide LA


- pKa 7.7


- 33% unionised at pH 7.4


- Rel lipid solubility 50 (heptane-buffer coefficient 0.9)

- Structure


- pKa


- % unionised at 7.4


- Lipid solubility

Pharmacokinetic properties of prilocaine

- PPB 55%


- Most rapidly metabolised amide LA (liver, kidney, lung)


- O-toluidine may precipitate methaemoglobinaemia


- Elimination half life 100 min

- Protein binding


- metabolism


- elimination half life

Pharmacodynamic properties of prilocaine

- Relative potency 2


- Onset fast


- Duration moderate


- Toxic plasma conc >5 mcg/ml


- Safe dose 6 mg/kg or 9 mg/kg with adrenaline

- potency


- onset


- duration


- toxic plasma conc


- safe dose

Physiochemical properties of cocaine

- Ester LA


- pKa 8.6


- 5% unionised at pH 7.4

- Structure


- pKa


- % unionised at 7.4



Pharmacokinetic properties of cocaine

- 95% PPB


- significant hepatic hydrolysis to inactive products which are excreted in the urine


- elimination half life 100 min

- protein binding


- metabolism


- elimination half life

Pharmacodynamic properties of cocaine

- MOA: blocks uptake 1 and MAO while also stimulating the CNS, so increased risk of hypertension and arrhythmias


- moderate onset


- short duration


- toxic plasma conc 0.5 mcg/ml


- vasoconstrictor at all doses

- MOA


- Onset


- Duration


- Toxic plasma conc